StonvexLoading…
StonvexStonvexStonvexCore line items from CNC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $174.58B | $145.50B | $140.09B | $135.48B |
Operating Income | $-7.62B | $3.17B | $2.93B | $1.32B |
Net Income | $-6.67B | $3.31B | $2.70B | $1.20B |
EPS (Diluted) | $-13.53 | $6.31 | $4.95 | $2.07 |
Total Assets | $76.75B | $82.44B | $84.64B | $76.87B |
Total Liabilities | $56.69B | $55.94B | $58.69B | $52.63B |
Cash & Equivalents | $17.89B | $14.06B | $17.19B | $12.07B |
Free Cash Flow OCF − CapEx | $4.32B | $-490.00M | $7.25B | $5.26B |
Shares Outstanding | 491.76M | 495.91M | 534.48M | 550.75M |